Skip to content

Net margin at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
-1.9%-0.9pp
Ardelyx logo
ArdelyxARDX
-13.6%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
-9.5%-2.7pp
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
121.5%+103pp
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
10%+8.1pp
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
37.1%+0.2pp

Other financials

Income statement

See full
Revenue$106.5M+159%
Operating income$72.6M+349%
Net income$40.8M+209%
EPS (diluted)$0.24+204%

Balance sheet

See full
Cash & equivalents$220.5M+103%
Total debt$212.4M+1,323%
Total equity-$217.1M+35.0%
Total assets$434.6M+32.8%

Cash flow

See full
Operating cash flow$5.1M-74.3%
CapEx-
Free cash flow$74.6M+390%

Valuation

See full
Market cap$632.12M+457%
Enterprise value$624M+3,024%
P/E6.2×
P/S1.8×+1.4×

Profitability

See full
Gross margin99.2%
Operating margin55.4%+38.7pp
FCF margin24.7%-11.1pp

Returns & leverage

See full
Return on equity29.7%-138pp
Debt / equity-0.5×
Current ratio1.4×-1.9×

Where this comes from

Calculated from Ironwood Pharmaceuticals’s reported figures.

Based on trailing twelve months.

The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ironwood Pharmaceuticals's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ironwood Pharmaceuticals's net margin?
Ironwood Pharmaceuticals (IRWD) reported net margin of 28.3% in Q1 2026.
How has Ironwood Pharmaceuticals's net margin changed year-over-year?
Ironwood Pharmaceuticals's net margin increased by 377.6% year-over-year, from -10.2% to 28.3%.
What is the long-term trend for Ironwood Pharmaceuticals's net margin?
Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's net margin has grown at a -21.5% compound annual growth rate (CAGR), from 27.3% to 8.1%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.